|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
US5567584A
(en)
|
1988-01-22 |
1996-10-22 |
Zymogenetics, Inc. |
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
|
|
US6018026A
(en)
|
1988-01-22 |
2000-01-25 |
Zymogenetics, Inc. |
Biologically active dimerized and multimerized polypeptide fusions
|
|
NZ235148A
(en)
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
|
MX9204374A
(es)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
|
SE9201073D0
(sv)
|
1992-04-03 |
1992-04-03 |
Kabi Pharmacia Ab |
Protein formulation
|
|
WO1994010308A1
(en)
|
1992-10-23 |
1994-05-11 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
|
US5656261A
(en)
|
1995-01-18 |
1997-08-12 |
The Picower Institute For Medical Research |
Preventing and reversing advanced glycosylation endproducts
|
|
CN1142778C
(zh)
|
1995-01-18 |
2004-03-24 |
奥尔顿有限公司 |
噻唑鎓化合物用于预防和逆转高级糖基化终产物形成的用途
|
|
FI119756B
(fi)
|
1995-01-18 |
2009-03-13 |
Alteon Inc |
Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa
|
|
JPH11504316A
(ja)
|
1995-04-05 |
1999-04-20 |
ザ ピコワー インスティテュート フォア メディカル リサーチ |
進行性グリコシル化終末産物に結合する薬剤及びその使用方法
|
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
|
US6267958B1
(en)
*
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
AU1832797A
(en)
|
1996-01-26 |
1997-08-20 |
Trustees Of Columbia University In The City Of New York, The |
A polypeptide from lung extract which binds amyloid-beta peptide
|
|
US5864018A
(en)
|
1996-04-16 |
1999-01-26 |
Schering Aktiengesellschaft |
Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
|
|
WO1997039121A1
(en)
|
1996-04-16 |
1997-10-23 |
Schering Aktiengesellschaft |
Advanced glycosylation end-product receptor peptides and uses therefor
|
|
US7081241B1
(en)
|
1998-10-06 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Extracellular rage binding protein (EN-RAGE) and uses thereof
|
|
US7258857B2
(en)
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
|
US6555651B2
(en)
|
1997-10-09 |
2003-04-29 |
The Trustees Of Columbia University In The City Of New York |
Ligand binding site of rage and uses thereof
|
|
US6790443B2
(en)
|
1996-11-22 |
2004-09-14 |
The Trustees Of Columbia University In The City Of New York |
Method for treating symptoms of diabetes
|
|
JP2001514661A
(ja)
|
1997-03-11 |
2001-09-11 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病の処置における使用のための薬剤の同定
|
|
US7101838B2
(en)
|
1997-08-05 |
2006-09-05 |
The Trustees Of Columbia University In The City Of New York |
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
|
|
MY131805A
(en)
|
1997-09-18 |
2007-09-28 |
Biogen Idec Inc |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
|
|
US6380165B1
(en)
|
1997-09-19 |
2002-04-30 |
The Picower Institute For Medical Research |
Immunological advanced glycation endproduct crosslink
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US6323218B1
(en)
|
1998-03-11 |
2001-11-27 |
The General Hospital Corporation |
Agents for use in the treatment of Alzheimer's disease
|
|
US20020102604A1
(en)
|
1999-12-08 |
2002-08-01 |
Milne Edwards Jean-Baptiste Dumas |
Full-length human cDNAs encoding potentially secreted proteins
|
|
US6465422B1
(en)
|
1998-04-17 |
2002-10-15 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting tumor invasion or spreading in a subject
|
|
US6706683B1
(en)
|
1998-09-29 |
2004-03-16 |
Asahi Kasei Pharma Corporation |
Method for controlling the release of granules
|
|
US6753150B2
(en)
|
1998-10-05 |
2004-06-22 |
The Trustees Of Columbia University In The City Of New York |
Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
|
|
KR100731820B1
(ko)
*
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
EP1121454B1
(en)
|
1998-10-06 |
2007-11-14 |
The Trustees of Columbia University in the City of New York |
Extracellular novel rage binding protein (en-rage) and uses thereof
|
|
US6197294B1
(en)
|
1998-10-26 |
2001-03-06 |
Neurotech S.A. |
Cell surface molecule-induced macrophage activation
|
|
US6605642B2
(en)
|
1999-04-05 |
2003-08-12 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGES)
|
|
US6589944B1
(en)
|
1999-04-05 |
2003-07-08 |
City Of Hope |
Breakers of advanced glycation endproducts
|
|
US6787566B2
(en)
|
1999-04-05 |
2004-09-07 |
City Of Hope |
Breakers of advanced glycation endproducts
|
|
US6939545B2
(en)
|
1999-04-28 |
2005-09-06 |
Genetics Institute, Llc |
Composition and method for treating inflammatory disorders
|
|
US6835200B2
(en)
|
1999-06-22 |
2004-12-28 |
Ndo Surgical. Inc. |
Method and devices for tissue reconfiguration
|
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
|
WO2001012598A2
(en)
|
1999-08-13 |
2001-02-22 |
The Trustees Of Columbia University In The City Of New York |
METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF
|
|
WO2001018060A1
(fr)
|
1999-09-08 |
2001-03-15 |
Toray Industries, Inc. |
Materiaux de circulation extracorporelle, adsorbants de facteurs de complication diabetique, reservoirs servant a eliminer des facteurs de complication diabetique et procede d'elimination de facteurs de complication diabetique
|
|
US20050170382A1
(en)
|
1999-10-06 |
2005-08-04 |
The Trustees Of Columbia University In The City Of New York. |
RAGE-related compositions
|
|
IL143936A0
(en)
|
1999-10-21 |
2002-04-21 |
Univ Case Western Reserve |
Gene expression profiling of inflammatory bowel disease
|
|
EP1272843B1
(en)
|
2000-04-14 |
2007-06-20 |
Niadyne Corporation |
Method for identifying regulators of protein-age formation
|
|
WO2001079849A2
(en)
|
2000-04-17 |
2001-10-25 |
Trans Tech Pharma |
Protein expression system arrays and use in biological screening
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
US6563015B1
(en)
|
2000-08-14 |
2003-05-13 |
The Trustees Of Columbia University In The City Of New York |
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
|
|
EP1334207A2
(en)
|
2000-10-02 |
2003-08-13 |
Reddy US Therapeutics, Inc. |
Methods and compositions for the treatment of inflammatory diseases
|
|
WO2002030889A2
(en)
|
2000-10-13 |
2002-04-18 |
The Trustees Of Columbia University In The City Of New York |
A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
|
|
US20050244849A1
(en)
|
2000-12-15 |
2005-11-03 |
Genetics Institute, Llc |
Screening assays for rheumatoid arthritis
|
|
HUP0600450A2
(en)
|
2000-12-29 |
2006-09-28 |
Reddy Us Therapeutics |
Detection of compounds that modulate inflammatory responses
|
|
AU2002233340B2
(en)
|
2001-02-19 |
2008-05-22 |
Merck Patent Gmbh |
Artificial fusion proteins with reduced immunogenicity
|
|
JP3837494B2
(ja)
|
2001-03-19 |
2006-10-25 |
国立大学法人金沢大学 |
可溶型ｒａｇｅタンパク質
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US20060140933A1
(en)
|
2002-08-16 |
2006-06-29 |
Wyeth And Imperial College Innovations Limited |
Compositions and methods for treating rage-associated disorders
|
|
US8067371B2
(en)
|
2003-05-09 |
2011-11-29 |
The Trustees Of Columbia University In The City Of New York |
RAGE G82S-related methods and compositions for treating inflammatory disorders
|
|
US20050008649A1
(en)
|
2003-06-02 |
2005-01-13 |
University Of Miami |
Chimeric molecules and methods of use
|
|
EP1660014A4
(en)
|
2003-09-05 |
2009-07-22 |
Univ Columbia |
RAGE-RELATED METHODS AND COMPOSITIONS FOR TREATING GLOMERULAR DAMAGE
|
|
US20070167360A1
(en)
|
2003-10-31 |
2007-07-19 |
Yan Shi D |
Methods for treating multiple sclerosis
|
|
US20060012414A1
(en)
*
|
2004-07-15 |
2006-01-19 |
Texas Instruments Incorporated |
Circuit and method for generating a polyphase clock signal and system incorporating the same
|
|
EP1771565B1
(en)
|
2004-07-20 |
2012-09-05 |
The Feinstein Institute for Medical Research |
Rage protein derivatives
|
|
US20060040354A1
(en)
|
2004-07-20 |
2006-02-23 |
O'keefe Theresa L |
Novel polyadenylation signal for use in expression vectors
|
|
CN101010430A
(zh)
|
2004-08-03 |
2007-08-01 |
转化技术制药公司 |
Rage融合蛋白及使用方法
|
|
AU2005271452B2
(en)
|
2004-08-03 |
2011-11-03 |
Vtv Therapeutics Llc |
RAGE fusion proteins and methods of use
|
|
CA2581505A1
(en)
|
2004-09-27 |
2006-04-06 |
Centocor, Inc. |
Srage mimetibody, compositions, methods and uses
|
|
US20080207499A1
(en)
|
2005-06-29 |
2008-08-28 |
Gaetano Barile |
Rage-related methods for treating and preventing diabetic retinopathy
|
|
AU2007215503A1
(en)
*
|
2006-02-09 |
2007-08-23 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
WO2007130302A2
(en)
|
2006-05-05 |
2007-11-15 |
Transtech Pharma, Inc. |
Rage fusion proteins, formulations, and methods of use thereof
|
|
WO2008100470A2
(en)
|
2007-02-15 |
2008-08-21 |
Transtech Pharma, Inc. |
Rage - immunoglobulin fusion proteins
|